No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs543367224 |
chr17:34330366-34330367 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs569462977 |
chr17:34330402-34330403 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs374303037 |
chr17:34330409-34330410 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs78834229 |
chr17:34330411-34330412 |
Enhancers Weak transcription
|
CpG island
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs540836632 |
chr17:34330475-34330476 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs558928272 |
chr17:34330503-34330504 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs181412806 |
chr17:34330537-34330538 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs543894968 |
chr17:34330538-34330539 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs148351188 |
chr17:34330540-34330541 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs529903326 |
chr17:34330544-34330545 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs144286177 |
chr17:34330554-34330555 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs112512832 |
chr17:34330563-34330564 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs71914010 |
chr17:34330570-34330571 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs59189888 |
chr17:34330580-34330581 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs56267816 |
chr17:34330581-34330582 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs189507571 |
chr17:34330669-34330670 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs76144420 |
chr17:34330678-34330679 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs180987986 |
chr17:34330681-34330682 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs71366497 |
chr17:34330698-34330699 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs111614894 |
chr17:34330709-34330710 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs201643905 |
chr17:34330710-34330711 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs550776962 |
chr17:34330721-34330722 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs116271347 |
chr17:34330725-34330726 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs140152125 |
chr17:34330746-34330747 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs150327341 |
chr17:34330783-34330784 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs562537270 |
chr17:34330797-34330798 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs137874740 |
chr17:34330809-34330810 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs567669219 |
chr17:34330840-34330841 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs60380956 |
chr17:34330883-34330884 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs143396430 |
chr17:34330893-34330894 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs573464376 |
chr17:34330915-34330916 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs185220168 |
chr17:34330925-34330926 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs558596409 |
chr17:34330939-34330940 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs116832492 |
chr17:34330949-34330950 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs539149663 |
chr17:34330950-34330951 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs531184535 |
chr17:34330951-34330952 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs75478034 |
chr17:34330965-34330966 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs75456429 |
chr17:34330987-34330988 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs111983437 |
chr17:34331002-34331003 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs375407945 |
chr17:34331003-34331004 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs147150892 |
chr17:34331026-34331027 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs73990617 |
chr17:34331045-34331046 |
Enhancers Weak transcription
|
TF binding region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs73990618 |
chr17:34331084-34331085 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs191209799 |
chr17:34331116-34331117 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs576719814 |
chr17:34331147-34331148 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs532674218 |
chr17:34331157-34331158 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs532160521 |
chr17:34331160-34331161 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs183334540 |
chr17:34331177-34331178 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs187002694 |
chr17:34331182-34331183 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs530878188 |
chr17:34331194-34331195 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|